Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys - Related Studies

Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted Kidneys

This study has been completed.

Study NCT00001984. Last updated on June 18, 2008. Information provided by National Institutes of Health Clinical Center (CC)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Graft Rejection
		Kidney Disease

2	Additional conditions recognized in this trial
		Kidney Diseases

3	More general conditions related to this trial
		Urologic Diseases

4	Interventions listed in this trial
		Campath-1H

5	Additional drug interventions recognized in this trial
		Alemtuzumab

6	More general drug interventions related to this trial
		Antineoplastic Agents
		Pharmacologic Actions
		Therapeutic Uses

7	Sponsors listed in this trial
		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)